CHONDROECTODERMAL DYSPLASIA

CHONDROECTODERMAL DYSPLASIA was reported 1 times

CHONDROECTODERMAL DYSPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 B Lymphocyte Stimulator-specific Inhibitor [EPC] 1 0.0000
1 Purine Antimetabolite [EPC] 1 0.0000
2 Alkylating Drug [EPC] 1 0.0000
3 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
4 Platelet Aggregation Inhibitor [EPC] 1 0.0000
5 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000